Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERBIFORT: Cetuximab + FOLFIRI in Metastatic Colorectal Cancer
NCT00557102Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2007
- Primary completion
- Dec 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in colorectal cancer (CRC), sponsored by National Cancer Institute. Started Sep 2007; status: completed.
02
Drugs
cetuximab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00557102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00557102.